Klaria Pharma Holding AB Sustainability Reports
Klaria Pharma Holding AB is a clinical-stage pharmaceutical company that develops innovative, rapid-acting products. The company combines a patented drug delivery alginate film technology with well-proven substances to create novel treatments for medical conditions like migraine and opioid overdose.
Sector: Professional & technical services
Country: Sweden
Exchange: Nasdaq Stockholm
LEI: 529900YLMSNHNP7HOD11
FIGI: BBG009K3JBG9
2 reports from 2024 to 2025
